Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same? by Coates, L, Fitzgerald, O, Helliwell, P, Paul, C

A distinct syndrome including features of systemic sclerosis, erosive rheumatoid arthritis, anti-topoisomerase antibody, and rheumatoid factor. by Doran, M, Wordsworth, P, Bresnihan, B, Fitzgerald, O

GRAPPA 2016 Project Report by Helliwell, P, Fitzgerald, O, Coates, L, Callis Duffin, K, Mease, P

GRAPPA 2018 project report by Goel, N, Fitzgerald, O, Gladman, DD, Helliwell, PS, Kavanaugh, A, Maksymowych, WP, Mease, PJ, Ritchlin, CT, Coates, LC

Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease by Helliwell, P, Coates, L, Fitzgerald, O, Nash, P, Soriano, E, Husni, M, Hsu, M, Kanik, K, Hendrikx, T, Wu, J, Kudlacz, E

Tofacitinib improves composite endpoint measures of disease in patients with psoriatic arthritis by Helliwell, P, Coates, L, Fitzgerald, O, Nash, P, Soriano, E, Husni, M, Hsu, M, Kanik, K, Hendrikx, T, Wu, J, Kudlacz, E

Advancing research paradigms and pathophysiological pathways in psoriatic arthritis and ankylosing spondylitis: Proceedings of the 2017 Platform for the Exchange of Expertise and R... by Abraham, S, Barton, A, Eder, L, Lim, A, McGonagle, D, McHugh, N, Pennington, S, Sengupta, R, Siebert, S, Bowness, P, Schafer, P, Cullen, E, Fitzgerald, O

Remission in psoriatic arthritis—where are we now? by Coates, L, Conaghan, P, D'Agostino, M, De Wit, M, Fitzgerald, O, Kvien, T, Lories, R, Mease, P, Nash, P, Schett, G, Soriano, E, Emery, P

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 annual meeting: report and plan for completing the core outcome measurement set by Leung, Y, Orbai, A, Ogdie, A, Coates, L, De Wit, M, Callis Duffin, K, Eder, L, Gladman, D, Goel, N, Mease, P, Strand, V, Fitzgerald, O, Tillett, W

Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the... by Coates, L, Gladman, D, Nash, P, Fitzgerald, O, Kavanaugh, A, Kvien, T, Gossec, L, Strand, V, Rasouliyan, L, Pricop, L, Ding, K, Jugl, S, Gaillez, C, Future 2 Study Group

Endorsement of the 66/68 joint count for the measurement of musculoskeletal disease activity: OMERACT 2018 psoriatic arthritis workshop report by Duarte-García, A, Leung, Y, Coates, L, Beaton, D, Christensen, R, Craig, E, De Wit, M, Eder, L, Fallon, L, Fitzgerald, O, Gladman, D, Goel, N, Holland, R, Lindsay, C, Maxwell, L, Mease, P, Orbai, A, Shea, B, Strand, V, Veale, D, Tillett, W, Ogdie, A

A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. by Strange, A, Capon, F, Spencer, C, Knight, J, Weale, M, Allen, M, Barton, A, Band, G, Bellenguez, C, Bergboer, J, Blackwell, J, Bramon, E, Bumpstead, S, Casas, J, Cork, M, Corvin, A, Deloukas, P, Dilthey, A, Duncanson, A, Edkins, S, Estivill, X, Fitzgerald, O, Freeman, C, Giardina, E, Gray, E

A genome-wide asociation study identifies new psoriasis susceptibility loci and an interaction betwEn HLA-C and ERAP1 by Strange, A, Capon, F, Spencer, C, Knight, J, Weale, M, Allen, M, Barton, A, Band, G, Bellenguez, C, Bergboer, J, BlackweL, J, Bramon, E, Bumpstead, S, Casas, J, Cork, M, Corvin, A, Deloukas, P, Dilthey, A, Duncanson, A, Edkins, S, EstiviL, X, Fitzgerald, O, FrEman, C, Giardina, E, Gray, E